Company registration number 05734433 (England and Wales)
AMS CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
AMS CARE LIMITED
COMPANY INFORMATION
Directors
M. Chotai
S. Chotai
B. Chandarana
E. Chotai
(Appointed 2 June 2025)
S. I. Chotai
(Appointed 2 June 2025)
Secretary
C. Frandzis
Company number
05734433
Registered office
2 Ambassador House
Wolseley Road
Harrow
Middlesex
HA3 5RT
Auditor
HW Fisher Audit
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
Bankers
Natwest Bank Plc
59 High Street
Exeter
EX4 3D6
AMS CARE LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Profit and loss account
7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 22
AMS CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 1 -
The directors present the strategic report for the year ended 31 August 2025.
Review of the business
The principal activity of the company is the operation of a care home.
The company made a pre-tax profit of £387,601 (2024: £402,026) for the year on turnover of £5,820,581 (2024: £5,698,024).
At 31 August 2025, the company had net assets of £12,890,211 (2024: £12,700,626).
Principal risks and uncertainties
The principal risks and uncertainties facing the company are:
i) adverse findings by the Care Quality Commission (CQC);
ii) significant increases in interest rates;
iii) occupancy levels;
iv) slow paying debtors.
Management ensure that the care home is run to a high standard to meet CQC requirements and attract residents.
The directors continually review risks and uncertainties throughout the period and believe that they have the management and systems in place to deal with changing situation.
Key performance indicators
In the opinion of the directors, there are two principal ratios which management consider on a regular basis to gain an understanding of the development, performance or position of the business:
i) occupancy levels;
ii) wages and salaries to turnover.
Theses ratios are taken into consideration by management on a quarterly review of the management accounts.
M. Chotai
Director
22 July 2026
AMS CARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
The directors present their report and accounts for the year ended 31 August 2025.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £nil (2024: £85,000).
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
M. Chotai
S. Chotai
B. Chandarana
E. Chotai
(Appointed 2 June 2025)
S. I. Chotai
(Appointed 2 June 2025)
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
On behalf of the board
M. Chotai
Director
22 July 2026
AMS CARE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
AMS CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF AMS CARE LIMITED
- 4 -
Opinion
We have audited the financial statements of AMS Care Limited (the 'company') for the year ended 31 August 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 August 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
AMS CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF AMS CARE LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
As part of our planning process:
We enquired of management the systems and controls the company has in place, the areas of the financial statements that are most susceptible to the risk of irregularities and fraud, and whether there was any known, suspected or alleged fraud. The company did not inform us of any known, suspected or alleged fraud.
We obtained an understanding of the legal and regulatory frameworks applicable to the group and company. We determined that the following were most relevant: FRS 102, Companies Act 2006, Health and Safety Act, The Care Act 2014.
We considered the incentives and opportunities that exist in the company, including the extent of management bias, which present a potential for irregularities and fraud to be perpetuated, and tailored our risk assessment accordingly.
Using our knowledge of the company, together with the discussions held with the group and company at the planning stage, we formed a conclusion on the risk of misstatement due to irregularities including fraud and tailored our procedures according to this risk assessment.
The key procedures we undertook to detect irregularities including fraud during the course of the audit included:
Identifying and testing journal entries and the overall accounting records, in particular those that were significant and unusual.
Reviewing the financial statement disclosures and determining whether accounting policies have been appropriately applied.
Reviewing and challenging the assumptions and judgements used by management in their significant accounting estimates, in particular in relation to valuation of freehold property used in the business.
Assessing the extent of compliance, or lack of, with the relevant laws and regulations.
Testing key revenue lines for evidence of management bias.
Performing a physical verification of key assets
Obtaining third-party confirmation of material bank and loan balances.
Documenting and verifying all significant related party balances and transactions.
Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the directors.
AMS CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF AMS CARE LIMITED (CONTINUED)
- 6 -
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Diccon Thornely (Senior Statutory Auditor)
For and on behalf of HW Fisher Audit, Statutory Auditor
Chartered Accountants
Acre House
11-15 William Road
London
NW1 3ER
United Kingdom
22 July 2026
AMS CARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 AUGUST 2025
- 7 -
2025
2024
Notes
£
£
Turnover
3
5,820,581
5,698,024
Cost of sales
(3,677,971)
(3,905,625)
Gross profit
2,142,610
1,792,399
Administrative expenses
(1,544,378)
(1,161,149)
Other operating income
40,393
60,363
Operating profit
4
638,625
691,613
Interest receivable and similar income
7
71,424
82,340
Interest payable and similar expenses
8
(322,448)
(371,927)
Profit before taxation
387,601
402,026
Tax on profit
9
(198,016)
(112,004)
Profit for the financial year
189,585
290,022
The profit and loss account has been prepared on the basis that all operations are continuing operations.
AMS CARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 AUGUST 2025
- 8 -
2025
2024
£
£
Profit for the year
189,585
290,022
Other comprehensive income
-
-
Total comprehensive income for the year
189,585
290,022
AMS CARE LIMITED
BALANCE SHEET
AS AT
31 AUGUST 2025
31 August 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
11
18,746,520
19,276,492
Current assets
Stocks
12
3,070
3,990
Debtors
13
460,904
200,958
Cash at bank and in hand
2,520,323
2,677,294
2,984,297
2,882,242
Creditors: amounts falling due within one year
14
(2,436,883)
(2,829,311)
Net current assets
547,414
52,931
Total assets less current liabilities
19,293,934
19,329,423
Creditors: amounts falling due after more than one year
15
(4,448,772)
(4,694,645)
Provisions for liabilities
Deferred tax liability
17
1,954,951
1,934,152
(1,954,951)
(1,934,152)
Net assets
12,890,211
12,700,626
Capital and reserves
Called up share capital
19
1,000,000
1,000,000
Share premium account
943,654
943,654
Revaluation reserve
8,330,799
8,710,506
Profit and loss reserves
2,615,758
2,046,466
Total equity
12,890,211
12,700,626
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 22 July 2026 and are signed on its behalf by:
M. Chotai
Director
Company registration number 05734433 (England and Wales)
AMS CARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2025
- 10 -
Share capital
Share premium account
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 September 2023
1,000,000
943,654
9,089,271
1,462,679
12,495,604
Year ended 31 August 2024:
Profit and total comprehensive income
-
-
-
290,022
290,022
Dividends
10
-
-
-
(85,000)
(85,000)
Transfers
-
-
(378,765)
378,765
-
Balance at 31 August 2024
1,000,000
943,654
8,710,506
2,046,466
12,700,626
Year ended 31 August 2025:
Profit and total comprehensive income
-
-
-
189,585
189,585
Transfers
-
-
(379,707)
379,707
-
Balance at 31 August 2025
1,000,000
943,654
8,330,799
2,615,758
12,890,211
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 11 -
1
Accounting policies
Company information
AMS Care Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Ambassador House, Wolseley Road, Harrow, Middlesex, HA3 5RT.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and certain financial instruments at fair value.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of AMS Care Holdings Limited. These consolidated financial statements are available from its registered office, 2 Ambassador Close, Wolseley Road, Harrow, Middlesex, HA3 5RT.
The principal accounting policies adopted are set out below.
1.2
Going concern
The financial statements have been prepared on a going concern basis. The directors have prepared cash flow forecasts covering a period of at least 12 months from the date of approval of the financial statements, which indicate that the company has sufficient resources to continue in operational existence. The directors have also considered available banking facilities and covenant compliance. true
Accordingly, at the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover represents the fair value of income receivable for the provision of residential and domiciliary care services during the year, net of any discounts or refunds. Income is recognised when the services have been provided, the amount can be measured reliably, and it is probable that the economic benefits will flow to the company, in accordance with FRS 102.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 12 -
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost or valuation less estimated residual value of each asset over its expected useful life, as follows:
Land and Freehold buildings
Straight line over 50 years
Plant and machinery
25% straight line
Motor vehicles
25% straight line
Land and assets in the course of construction are not depreciated.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 13 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 14 -
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 15 -
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.
Revaluation of freehold land and buildings
The Company’s freehold land and buildings comprise a specialised care home property and a residential apartment.
The care home property was independently valued in January 2023 by a qualified external valuer using an income approach based on maintainable EBITDA and an appropriate EBITDA multiple.
At 31 August 2025, management performed an updated valuation of the care home property using the same methodology, incorporating current and forecast trading information, to assess whether the carrying amount differed materially from fair value. This updated valuation was compared with the carrying amount (being the January 2023 revalued amount less accumulated depreciation). Management concluded that no material revaluation adjustment was required.
The residential apartment is assessed at each reporting date by reference to observable market information, including an online property valuation and local comparable transactions. Management concluded that the estimated fair value of the apartment did not differ materially from its carrying amount and therefore no revaluation adjustment was recognised.
The valuation of the care home property is sensitive to changes in maintainable EBITDA and the EBITDA multiple applied. A reasonably possible change in either assumption could result in the following impact on the carrying amount:
Assumption Change Impact on carrying amount
EBITDA multiple +0.25x +£506,257
EBITDA multiple -0.25x -£506,257
Maintainable EBITDA +5% +£911,263
Maintainable EBITDA -5% -£911,263
The sensitivities have been prepared by changing each assumption in isolation while holding all other assumptions constant. In practice, changes in assumptions may be interrelated.
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2025
2024
£
£
Turnover analysed by class of business
Fee income
5,820,581
5,698,024
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
3
Turnover and other revenue
(Continued)
- 16 -
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
5,820,581
5,698,024
2025
2024
£
£
Other revenue
Interest income
71,424
82,340
Grants received
-
14,031
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Government grants
-
(14,031)
Fees payable to the company's auditor for the audit of the company's financial statements
20,000
51,694
Depreciation of owned tangible fixed assets
655,821
634,039
Operating lease charges
1,368
1,368
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Cost of sales
81
84
Administration
8
3
Total
89
87
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
2,764,712
2,576,165
Social security costs
300,747
247,062
Pension costs
189,354
96,344
3,254,813
2,919,571
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 17 -
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
234,364
101,286
Remuneration disclosed above include the following amounts paid to the highest paid director:
2025
2024
£
£
Remuneration for qualifying services
115,899
-
As total directors' remuneration was less than £200,000 in the prior year, no disclosure is provided for that year.
7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
71,424
82,340
8
Interest payable and similar expenses
2025
2024
£
£
Interest on bank overdrafts and loans
322,448
371,144
Other interest
783
322,448
371,927
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
177,217
195,999
Adjustments in respect of prior periods
(2,353)
Total current tax
177,217
193,646
Deferred tax
Origination and reversal of timing differences
20,799
(81,642)
Total tax charge
198,016
112,004
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
9
Taxation
(Continued)
- 18 -
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
387,601
402,026
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
96,900
100,507
Tax effect of expenses that are not deductible in determining taxable profit
1,040
5,410
Tax effect of income not taxable in determining taxable profit
(11,069)
(11,069)
Adjustments in respect of prior years
(2,353)
Group relief
(37,738)
Depreciation on assets not qualifying for tax allowances
150,761
146,611
Deferred tax movements
(1,878)
1,048
Chargeable gains/(losses)
(128,150)
Taxation charge for the year
198,016
112,004
10
Dividends
2025
2024
£
£
Interim paid
85,000
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 19 -
11
Tangible fixed assets
Land and Freehold buildings
Plant and machinery
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 September 2024
19,974,090
247,207
288,424
20,509,721
Additions
938
94,304
30,607
125,849
Disposals
(40,765)
(40,765)
At 31 August 2025
19,975,028
300,746
319,031
20,594,805
Depreciation and impairment
At 1 September 2024
1,000,088
90,464
142,677
1,233,229
Depreciation charged in the year
515,094
69,458
71,269
655,821
Eliminated in respect of disposals
(40,765)
(40,765)
At 31 August 2025
1,515,182
119,157
213,946
1,848,285
Carrying amount
At 31 August 2025
18,459,846
181,589
105,085
18,746,520
At 31 August 2024
18,974,002
156,743
145,747
19,276,492
Freehold land and buildings are carried under the revaluation model in accordance with Section 17 of FRS 102.
The care home property was most recently independently valued in January 2023. At 31 August 2025, no formal revaluation was recognised as management concluded that the carrying amount remained not materially different from fair value based on an updated assessment using the same valuation methodology.
The residential apartment is assessed at each reporting date using observable market evidence, including external online valuation data and comparable transactions. No revaluation adjustment was considered necessary in the current year.
Land and buildings are carried at valuation. If land and buildings were measured using the cost model, the carrying amounts would have been approximately £6,590,392 (2024 - £6,725,359), being cost £8,505,160 (2024 - £8,504,222) and depreciation £1,914,768 (2024 - £1,778,863).
12
Stocks
2025
2024
£
£
Raw materials and consumables
3,070
3,990
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 20 -
13
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
180,757
131,048
Amounts owed by group undertakings
160,002
Prepayments and accrued income
120,145
69,910
460,904
200,958
14
Creditors: amounts falling due within one year
2025
2024
Notes
£
£
Bank loans
16
254,966
226,469
Trade creditors
178,336
60,173
Amounts owed to group undertakings
1,480,325
1,992,304
Corporation tax
177,232
196,014
Other taxation and social security
73,827
49,172
Other creditors
129,302
61,705
Accruals and deferred income
142,895
243,474
2,436,883
2,829,311
15
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
16
4,448,772
4,694,645
Amounts included above which fall due after five years are as follows:
Payable by instalments
3,234,201
3,609,924
16
Loans and overdrafts
2025
2024
£
£
Bank loans
4,703,738
4,921,114
Payable within one year
254,966
226,469
Payable after one year
4,448,772
4,694,645
The bank loan is secured by a debenture over the assets of the company and a first legal charge over the freehold property.
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
16
Loans and overdrafts
(Continued)
- 21 -
In June 2023 the company took out a 15 year repayment bank loan, with fixed monthly repayments. Interest is charged at 2.1% over base rate per annum. The loan will be repaid in full by a lump sum at the end of the term.
17
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
204,984
179,603
Revaluations
1,754,549
1,754,549
Short term timing differences
(4,582)
-
1,954,951
1,934,152
2025
Movements in the year:
£
Liability at 1 September 2024
1,934,152
Charge to profit or loss
20,799
Liability at 31 August 2025
1,954,951
18
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
189,354
96,344
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
19
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1,000,000
1,000,000
1,000,000
1,000,000
AMS CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 22 -
20
Related party transactions
At the year end, the company owed an amount of £nil (2024: £2,000) to the director, M Chotai.
During the year, the company was charged rent of £nil (2024: £27,000) payable to Chotai and Co, a business controlled by the director, M Chotai, for use of its premises.
21
Ultimate controlling party
The immediate and ultimate parent company is AMS Care Holdings Limited, a company incorporated in England and Wales (Registered Office: 2 Ambassador House, Wolseley Road, Harrow, Middlesex HA3 5RT).
The ultimate controlling parties are S Chotai and M. Chotai, by virtue of their control and ownership of AMS Care Holdings Limited.
The results of AMS Care Limited are incorporated within the consolidated financial statements of AMS Care Holdings Limited. Copies of the financial statements for this company and the group can be obtained from Companies House public registry.
2025-08-312024-09-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100No description of principal activityM. ChotaiS. ChotaiB. ChandaranaE. ChotaiS. I. ChotaiC. Frandzis057344332024-09-012025-08-3105734433bus:Director12024-09-012025-08-3105734433bus:Director22024-09-012025-08-3105734433bus:Director32024-09-012025-08-3105734433bus:Director42024-09-012025-08-3105734433bus:Director52024-09-012025-08-3105734433bus:CompanySecretary12024-09-012025-08-3105734433bus:RegisteredOffice2024-09-012025-08-3105734433bus:Agent12024-09-012025-08-31057344332025-08-31057344332023-09-012024-08-3105734433core:RetainedEarningsAccumulatedLosses2023-09-012024-08-3105734433core:RetainedEarningsAccumulatedLosses2024-09-012025-08-31057344332024-08-3105734433core:LandBuildingscore:OwnedOrFreeholdAssets2025-08-3105734433core:PlantMachinery2025-08-3105734433core:MotorVehicles2025-08-3105734433core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3105734433core:PlantMachinery2024-08-3105734433core:MotorVehicles2024-08-3105734433core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3105734433core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3105734433core:Non-currentFinancialInstrumentscore:AfterOneYear2025-08-3105734433core:Non-currentFinancialInstrumentscore:AfterOneYear2024-08-3105734433core:ShareCapital2025-08-3105734433core:ShareCapital2024-08-3105734433core:SharePremium2025-08-3105734433core:SharePremium2024-08-3105734433core:RevaluationReserve2025-08-3105734433core:RevaluationReserve2024-08-3105734433core:RetainedEarningsAccumulatedLosses2025-08-3105734433core:RetainedEarningsAccumulatedLosses2024-08-3105734433core:ShareCapital2023-08-3105734433core:SharePremium2023-08-3105734433core:RevaluationReserve2023-08-3105734433core:RetainedEarningsAccumulatedLosses2023-08-3105734433core:ShareCapitalOrdinaryShareClass12025-08-3105734433core:ShareCapitalOrdinaryShareClass12024-08-3105734433core:RevaluationReserve2023-09-012024-08-3105734433core:RevaluationReserve2024-09-012025-08-3105734433core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-012025-08-3105734433core:PlantMachinery2024-09-012025-08-3105734433core:MotorVehicles2024-09-012025-08-3105734433core:ConstructionInProgressAssetsUnderConstruction2024-09-012025-08-310573443312024-09-012025-08-310573443312023-09-012024-08-3105734433core:UKTax2024-09-012025-08-3105734433core:UKTax2023-09-012024-08-310573443322024-09-012025-08-310573443322023-09-012024-08-310573443332024-09-012025-08-310573443332023-09-012024-08-3105734433core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3105734433core:PlantMachinery2024-08-3105734433core:MotorVehicles2024-08-31057344332024-08-3105734433core:CurrentFinancialInstruments2025-08-3105734433core:CurrentFinancialInstruments2024-08-3105734433core:Non-currentFinancialInstruments2025-08-3105734433core:Non-currentFinancialInstruments2024-08-3105734433core:WithinOneYear2025-08-3105734433core:WithinOneYear2024-08-3105734433bus:OrdinaryShareClass12024-09-012025-08-3105734433bus:OrdinaryShareClass12025-08-3105734433bus:OrdinaryShareClass12024-08-3105734433bus:PrivateLimitedCompanyLtd2024-09-012025-08-3105734433bus:FRS1022024-09-012025-08-3105734433bus:Audited2024-09-012025-08-3105734433bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP